Global Ophthalmic Surgery Devices Market Size By Type (Bench-Top, Portable), By Application (Refractive Error Surgery Devices, Cataract Surgery Devices), By Region, And Segment Forecasts, 2023 to 2032

The Global Ophthalmic Surgery Devices Market was valued at USD 10.4 billion in 2023 and is projected to reach USD 18.7 billion by 2031, expanding at a CAGR of 7.4% from 2023 to 2031. This growth is fueled by the increasing prevalence of eye disorders such as cataracts, glaucoma, and refractive errors, along with the rising geriatric population globally. Moreover, the growing adoption of minimally invasive surgical procedures, technological advancements in surgical devices, and improved healthcare access in emerging economies are contributing significantly to market expansion.

Drivers

1. Rising Prevalence of Eye Disorders:

Globally, conditions like cataracts, glaucoma, and age-related macular degeneration are increasing due to the aging population and lifestyle-related diseases such as diabetes. This drives demand for ophthalmic surgical interventions and associated devices.

2. Technological Advancements in Surgical Tools:

Ongoing innovation, including femtosecond lasers, micro-incision tools, and 3D visualization systems, has revolutionized ophthalmic surgeries, enhancing precision and reducing recovery time.

3. Growth in Geriatric Population:

As elderly individuals are more prone to developing visual impairments, their increasing numbers globally is a major contributor to the growing need for surgical eye treatments.

Restraints

1. High Cost of Devices and Procedures:

Advanced ophthalmic surgical devices are capital-intensive, and the high cost of associated surgeries limits adoption, particularly in low- and middle-income regions.

2. Shortage of Skilled Ophthalmic Surgeons:

The effectiveness of advanced surgical devices relies on skilled professionals. A shortage of trained ophthalmologists can hinder the full utilization of sophisticated devices in certain regions.

Opportunity

1. Expanding Healthcare Infrastructure in Emerging Economies:

Countries across Asia-Pacific and Latin America are increasingly investing in healthcare infrastructure, offering lucrative opportunities for ophthalmic surgery device manufacturers to expand their presence.

2. Rising Demand for Outpatient and Minimally Invasive Procedures:

The preference for outpatient procedures and minimally invasive surgeries is rising, creating a favorable market environment for compact, efficient surgical devices.

Market by System Type Insights

The Cataract Surgery Devices segment accounted for the largest share in 2023. As cataract surgeries are among the most commonly performed procedures worldwide, phacoemulsification devices, intraocular lenses (IOLs), and ophthalmic viscoelastic devices remain in high demand. The Refractive Surgery Devices segment is also expected to grow substantially due to increasing adoption of LASIK and SMILE techniques among younger populations seeking vision correction.

Market by End-use Insights

Hospitals held the dominant market share in 2023, driven by the availability of advanced surgical equipment and specialized ophthalmologists. Ambulatory Surgical Centers (ASCs) are expected to register the fastest growth over the forecast period due to lower procedural costs, shorter recovery times, and patient preference for minimally invasive outpatient services.

Market by Regional Insights

North America led the global ophthalmic surgery devices market in 2023, supported by advanced healthcare infrastructure, high awareness, and early adoption of cutting-edge technologies. Asia-Pacific is anticipated to witness the highest CAGR during the forecast period due to the rapidly aging population, increasing healthcare spending, and government initiatives to enhance eye care services.

Competitive Scenario

Key players in the Global Ophthalmic Surgery Devices Market include:

Alcon Inc.

Carl Zeiss Meditec AG

Bausch + Lomb Incorporated

Johnson & Johnson Vision

Topcon Corporation

HOYA Corporation

NIDEK Co., Ltd.

Ziemer Ophthalmic Systems AG

Lumenis

STAAR Surgical Company

These companies are actively engaging in R&D, product innovation, and strategic mergers & acquisitions to expand their market share. For instance:

In 2023, Alcon introduced a next-generation femtosecond laser platform to enhance precision in cataract surgery.

Johnson & Johnson Vision launched an advanced toric intraocular lens (IOL) in 2022 to address astigmatism with higher accuracy.

Scope of Work – Global Ophthalmic Surgery Devices Market

Report Metric Details

Market Size (2023) USD 10.4 billion

Projected Market Size (2031) USD 18.7 billion

CAGR (2023–2031) 7.4%

Market Segments By System Type, By End-use, By Region

Growth Drivers Prevalence of Eye Diseases, Technological Advancements, Geriatric Population

Opportunities Emerging Market Expansion, Minimally Invasive Procedure Demand